Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sipeifu Biotechnology is a leading Chinese life sciences company specializing in the research, development, and production of high-end experimental animal models. The company focuses on providing Specific Pathogen Free (SPF) laboratory animals, including genetically modified mice and rats, which serve as critical tools for preclinical drug discovery and biomedical research. Sipeifu offers a comprehensive suite of contract research organization (CRO) services, such as gene editing for model customization, animal breeding, phenotypic analysis, and efficacy testing. Their state-of-the-art facilities in Beijing and Langfang adhere to international standards for animal welfare and standardized production. By supplying high-quality, standardized experimental models, Sipeifu supports pharmaceutical companies and academic institutions in therapeutic areas like oncology, immunology, and metabolic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sipeifu Biotechnology.